Skip to main content
. Author manuscript; available in PMC: 2019 Nov 11.
Published in final edited form as: Anticancer Res. 2018 Nov;38(11):6361–6366. doi: 10.21873/anticanres.12994

Table I.

Clinical characteristics of patients.

Variable Gleason score
6 7 8–9 All
Cases (N) 28 28 28 84
Age* (years; mean) 56.8 60.1 60.9 59.3
Age (years; range) 47.5–66.5 48.0–74.4 45.3–78.8 45.3–78.8
Race (N)
 Caucasians 13 14 0 27
 African Americans 15 14 28 57
Androgen deprivation treatment (N)
 No 24 19 17 60
 Yes 0 1 10 11
 Unknown 4 8 1 13
*

Age of patients at radical prostatectomy; one patient’s age could not be determined.

Androgen deprivation treatment began after radical prostatectomy for all patients except one. N: Actual number of patients.